Atlas Trials

Randomized Placebo Controlled Study to Determine Safety, Pharmacodynamics and Efficacy of ILV-094 in Atopic Dermatitis

Clinical trial NCT01941537 · COMPLETED

Trial details

NCT number
NCT01941537
Sponsor
Rockefeller University
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Atopic Dermatitis
Start date
2013-10-01
Primary completion
2016-02-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.